Lv3
315 积分 2022-10-03 加入
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
7天前
已完结
Pleural mesothelioma
7天前
已完结
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons
7天前
已完结
Amivantamab, lazertinib, and bevacizumab: a chemotherapy-free option for patients with advanced EGFR-mutant NSCLC with acquired resistance to a third-generation EGFR TKI
9天前
已完结
Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial
9天前
已完结
Biases in the Interpretation of TRANSFORM Circulating Tumor DNA Data: Assessment Timing, Event Definition, and Subset Selection
9天前
已关闭
Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial
9天前
已完结
Biases in the Interpretation of TRANSFORM Circulating Tumor DNA Data: Assessment Timing, Event Definition, and Subset Selection
16天前
已关闭
边界可切除食管癌诊治的再思考
16天前
已完结
Risk Factors for Anastomotic Stricture Post-esophagectomy with a Standardized Sutured Anastomosis
19天前
已完结
皖公网安备34019202002308
